• The new facility is designed to demonstrate the company’s innovative Ultra Shear Technology’s ability to create CBD oil nanoemulsions of superior stability, aesthetics, and bioavailability
• Company has received orders for nine UST-based BaroShear K45 proprietary systems, with three more anticipated shortly, for an overall value of $2.4 million
• Global nanoemulsion market estimated to rise to $14.91 billion by the end of 2025

Pressure BioSciences Inc. (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, and other industries, recently announced the opening of their new Ultra Shear Technology(TM) Demonstration Laboratory, located in the company’s South Easton, MA facility (http://ibn.fm/veoMI).

The main goal of the UST Demo Lab is to showcase the ability of the company’s revolutionary UST Platform to process cannabidiol (CBD) oil into water-soluble nanoemulsions of superior quality. CBD nanoemulsions are expected to be more stable and offer higher bioavailability than the standard macro and microemulsions used in the vast majority of CBD products today.

The second objective is to invite potential purchasers of the company’s BaroShear nanoemulsification system to evaluate how their CBD and other product formulations work with the company’s revolutionary UST platform. The company expects to install and invoice the initial 12 BaroShear K45 systems in the fourth quarter of 2020.

CBD and other cannabinoids are extracted from hemp in an oil form. As with any oil-based product, it is difficult for the water-based biology of the human body to access and absorb CBD molecules from relatively large hemp oil drops. This varying, poor absorption of CBD results in reduced bioavailability of the CBD molecule in the body. Low or widely varying absorption levels and bioavailability of CBD have a negative impact on the effective delivery of many CBD products’ potential benefits.

“We processed samples of CBD oil formulations from several highly interested companies over the past two months, in an effort to optimize the service we announced today,” Kenneth F. Micciche, UST Program director, stated in a news release. “The ability to showcase the UST platform in real life, and see the final product first-hand, has been shown to be vital to our marketing efforts. The opening of the UST Demo Lab is a critical accomplishment in our UST sales and marketing strategy.”

The UST Platform’s efficiency has already brought Pressure BioSciences several orders for the proprietary UST-based BaroShear K45 Systems. On January 24, the company announced it had received an order for six BaroShear K45 systems from Vegas CBD Factory, to be delivered and installed in the fourth quarter of 2020. This brings the total number of systems on order to nine and, what’s more, the company expects additional orders shortly. When these are received, the planned initial build of 12 systems will sell out with approximate total value of $2.4 million (http://ibn.fm/XpHEF).

In addition to CBD, Pressure BioSciences’ innovative pressure-based instruments are also used successfully in many different healthcare areas, such as supporting important research studies in new treatments for cancer, stroke, heart disease, infectious diseases and Alzheimer’s. UST therefore has the potential to have a significant impact in many multi-billion-dollar markets in addition to cannabis, such as cosmetics, nutraceuticals, pharmaceuticals, and foods and beverages.

The company is also uniquely positioned to leverage an increasing number of opportunities on the fast-growing nanoemulsion market. According to Transparency Market Research, the market will see exponential growth over the next few years, being expected to reach $14.91 billion by the end of 2025 from $6.78 billion in 2016 (http://ibn.fm/wvCVi).

For more information, visit the company’s website at www.PressureBioSciences.com

NOTE TO INVESTORS: The latest news and updates relating to PBIO are available in the company’s newsroom at http://ibn.fm/PBIO

• SPRWF to focus on accelerated near-term revenue moving forward
• Announces the launch of new brands in the Canadian market
• SPRWF well-positioned to accelerate CPG-focused transition

The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1), a company dedicated to growing the world’s best cannabis and becoming a leader in the global cannabis industry, released its financial and operating results for 2019, noting a focus on accelerated near-term revenue growth and 17% year-over-year net revenue growth (http://ibn.fm/5985Y). The company also shared an update on its strategy and outlook for the remainder of fiscal 2020.

In the announcement, Supreme Cannabis detailed how the Canadian business would benefit from its coast-to-coast sales partnership with humble+fume; the company also announced its goal of reaching near-term profitability, in part, enabled by its enhanced cost structure and accelerated revenue generating initiative. The company also highlighted that with major construction complete on its facilities, minimal capital expenditure is required moving forward. With cost optimization underway and significantly reduced capital expenditure ahead, the company is well positioned to execute moving forward. Most recently, Supreme Cannabis reported a strong liquidity position with total cash and restricted cash balance of $55 million with $35 million of undrawn capacity on the company’s credit facility.

Supreme Cannabis reiterated its strategy to transition from a business to business model to a consumer-facing premium-cannabis business. A focus on expanding its consumer-facing product portfolio is expected to drive near-term revenue with new high-quality for a variety of consumers hitting the market in the coming months. This expanded portfolio will be supported by an innovative sales model that achieves comprehensive distribution to cannabis retailers across Canada.

“As we realign our structure and expectations with the current state of the industry, I maintain my strong belief in Supreme Cannabis’ ability to drive near-term revenue growth, profitability and long-term value with new high-quality brands and products at every key price segment,” Supreme Cannabis interim president and CEO Colin Moore stated in a news release. “I’m proud of the team’s progress and difficult work rightsizing the company’s cost structure and focusing the business on near-term revenue drivers. As one of the few licensed producers with completed cultivation infrastructure and in-house, value-added processing capabilities, as well as proven premium brands in the recreational market, we are well positioned to accelerate our CPG-focused transition. Our strong liquidity position, including the credit facility arranged by a tier-one bank, further ensures we have the capital necessary to execute going forward.”

Looking forward, Supreme Cannabis plans new product launches designed to provide consumers with convenient, accessible consumption experiences. In addition, the company anticipates expanding its brand portfolio with recreational brands that address the ultra-premium and value segments. Finally, in Q3 2020, Supreme Cannabis expects to launch its first 2.0 products in the form of 7ACRES’s branded PAX ERA vaporizer pods.

The Supreme Cannabis Company is a global, diversified portfolio of distinct cannabis companies, products and brands. Since 2014, SPRWF has emerged as one of the world’s fastest-growing, premium, plant-driven lifestyle companies. Supreme Cannabis’ brands are backed by a focused suite of world-class operating assets that serve key functions in the value chain, including scaled cultivation, value-add processing, centralized manufacturing and product testing, and research and development.

For more information, visit the company’s website at www.Supreme.ca

NOTE TO INVESTORS: The latest news and updates relating to SPRWF are available in the company’s newsroom at http://ibn.fm/SPRWF

• SHRM issues almost 19 million common shares in conjunction with IPO offering; raises more than $2.8 million
• Flagship product line is Vitality Superteas, infused with proprietary formulation of artisanal mushrooms
• National Institutes of Health (NIH) and Good Housekeeping extol health benefits of mushrooms

Champignon Brands Inc. (CSE: SHRM), a research-driven company specializing in the formulation and distribution of artisanal-mushroom health supplements, has completed its IPO and is now listed on the Canadian Stock Exchange. Based in Vancouver, British Columbia, Champignon issued 18,916,667 common shares in conjunction with the IPO offering, raising $2,837,500 in gross proceeds in the market transaction (http://ibn.fm/w3zN6).

The Champignon suite of products is built around the company’s belief that mushrooms enhance the health and wellness of its consumers – a notion that appears to be well founded. Numerous research studies tout the benefits of mushrooms. Champignon is aggressively pursuing its mission of researching and distributing premium medicinal mushrooms-infused products, which target high-margin markets, as well as consumers interested in the health and wellness benefits associated with mushrooms.

“Nowadays, mushrooms are popular valuable foods because they are low in calories, carbohydrates, fat, and sodium,” states an article published by the Journal of Microbiology on the National Institutes of Health (NIH) website (http://ibn.fm/KU35M). “Also, they are cholesterol-free. Besides, mushrooms provide important nutrients, including selenium, potassium, riboflavin, niacin, vitamin D, proteins, and fiber. All together with a long history as food source, mushrooms are important for their healing capacities and properties in traditional medicine. It has reported beneficial effects for health and treatment of some diseases.”

A Good Housekeeping article (http://ibn.fm/EPLPH) notes that “although white foods are often thought to be nutrient-poor, mushrooms are an exception… They contain many minerals, like selenium, potassium, copper, iron and phosphorus, that are not often found in plant-derived foods.” Given their fully loaded nutrient list, it’s no wonder mushrooms are identified as a superfood.

Capitalizing on the benefits of the mighty mushroom is Champignon Brands, which specializes in mushroom health supplements that promote holistic health and wellness. The company offers a mushroom-infused portfolio of products, including its flagship product line: Vitality Superteas. In addition, Champignon has signed an R&D agreement and product formulation partnership with Canadian-based Drip Coffee Social Ltd.

Vitality Superteas are conventional organic teas that combine a proprietary mix of artisanal mushrooms that are sold through influencer marketing on social media and online (http://ibn.fm/vUgQi). Champignon’s Superteas include Nourish Force Supertea, Mighty Recharge Supertea and Brain Enhance Supertea.

Recent research finds that the global market for functional consumer products infused with the nutritional benefits of mushrooms is projected to reach $34.3 billion by 2024 and grow at a compound annual rate (CAGR) of 8.04% from 2019-2024 (http://ibn.fm/FmlBl). The research also sees Europe as the fastest-growing market. With its innovative product line, Champignon poses an attractive option for investors looking to break into the health and wellness beverage industry.

For more information, visit the company’s website at www.ChampignonBrands.com

NOTE TO INVESTORS: The latest news and updates relating to SHRM are available in the company’s newsroom at http://ibn.fm/SHRM

• CIIX CEO discusses numerous health benefits of company’s CBD-based products during MoneyTV interview
• Company has engaged in international campaign in China, the U.S. to raise awareness of CBD oil’s myriad benefits
• CIIX is a compelling investment with tremendous opportunities in an enormous, untapped CBD Chinese market

Founded in 1999, ChineseInvestors.com Inc. (OTCQB: CIIX) is an established financial-information platform for Chinese-speaking investors in the United States and China. Recognizing significant opportunities offered by the nascent cannabis industry, the California-based company has leveraged its financial expertise to establish itself as a leader in China’s massive yet untapped cannabidiol (CBD) market.

China’s changing CBD laws can create volatility for CBD companies. However, those laws don’t apply to hemp-based CBD cosmetics, which are fully legal in China, Japan and the United States. Because CIIX is only involved in CBD cosmetics, the company remains unaffected by the changing regulations and is able to operate in a stable environment.

In a recent interview with MoneyTV’s Donald Baillargeon (http://ibn.fm/Z0MxX), CIIX CEO Warren Wang talked about the wide range of potential health benefits offered by the company’s CBD-based products. CIIX offers these CBD-based products through its subsidiary CBD Biotech and targets the massive Chinese market, where possible benefits of CBD oil have not yet been widely recognized. With a growing number of Chinese people becoming aware of these numerous health benefits, the time is ideal to promote hemp-based products as an option in dealing with outbreaks like the coronavirus. CBD Biotech already provides products on the market that may support those who wish to protect themselves and loved ones. Oils, soaps and cosmetics have the potential to help safeguard against the virus, said Wang.

CIIX has embarked on an international campaign to promote the benefits of the company’s CBD-based products, information that is particularly relevant in today’s environment where coronavirus is spreading around the world at an increasing speed. “We are, first of all, doing a radio show on Chinese AM 1300,” Wang noted. “Secondly, we did an infomercial article on one of the Chinese public WeChat groups. And thirdly, we did another infomercial on a New York radio show. We started creating some kind of awareness campaign for CBD oil. It’s a huge, huge market.”

Speaking about CIIX’s current efforts to promote the power of CBD oil, Wang announced that the company entered a deal with Vitamist, an organization that produces premium-quality supplements for health-conscious consumers. “Our company is very helpful for Chinese people,” added Wang. “I see tremendous opportunities here within the next three to six months to spread our word, create a community and then sell our products on CBDoil.com.”

With a decades-long successful track record, a robustly diversified business model and increased demand globally for its health and wellness products, CIIX is a compelling investment opportunity for investors seeking to harness the benefits of high potential companies.

For more information, visit the company’s website at www.ChineseInvestors.com

NOTE TO INVESTORS: The latest news and updates relating to CIIX are available in the company’s newsroom at http://ibn.fm/CIIX

• Exro has closed its second financing round, raising more than $4 million through private placement
• The company enters partnership with Finnish snowmobile producer to expand globally
• Successful financing rounds, international partnerships, inexhaustible market make XRO compelling high-growth investment opportunity

Exro Technologies Inc. (CSE: XRO) (OTCQB: EXROF), a Canadian technology company that develops intelligent energy-management systems designed to improve the performance and longevity of batteries, electric motors, and generators, has closed the second and final tranche of its oversubscribed, non-brokered private placement. The company raised $4,299,590 through the issuance of 12,284,545 common shares at a price of $0.35 per share (http://ibn.fm/2eDYb).

During this second tranche, XRO issued 2,253,897 shares for gross proceeds of $788,864. The company announced the closure of its first financing round last month (http://ibn.fm/eGwXn). In compliance with the prospectus and the relevant laws, the shares are subject to a four-month hold period from the date of issuance. Exro will use the funds raised in the private placement to finance the development of its current and new technology programs aimed at accelerating the global transition to clean energy, as well as for working capital, the development of its new Calgary Innovation Centre and other general business purposes.

XRO has also engaged in initiatives to penetrate new market segments by entering a strategic agreement with Finland’s Aurora Powertrains Oy. The Finnish partner, deemed one of the most innovative manufacturers of snowmobile powertrains globally, recently released eSled, an all-electric snowmobile. Exro and Aurora have teamed up to increase the snowmobile motor’s performance while decreasing the cost for future production.

“This is important as it takes Exro’s technology overseas to Europe and forms a key partnership with one of the transportation sector’s true innovators in the use of electric powertrains,” Exro CEO Sue Ozdemir stated in a news release.

The International Snow Machine Manufacturing Association’s (ISMA) latest research documents that the snowmobile sector has a global imprint with 124,786 snowmobiles sold worldwide in 2018. According to ISMA, the annual economic impact of snowmobiling is $26 billion in the United States, $8 billion in Canada, and $5 billion in Europe and Asia (http://ibn.fm/tMg3E).

Aurora CEO Ari Karjalainen confirmed the considerable value for both companies brought by this alliance. “Our company strategy is to strengthen our core competencies and, on the other hand, create partnerships with world-leading technology providers,” he said (http://ibn.fm/AN6Dr). “One step on this is cooperation with Exro, together with them, we are looking forward to working side-by-side to further develop the capabilities of our electric powertrain technology.” Karjalainen concluded that this is a growing global market that will continue to expand as consumers increasingly demand low-impact, no-emission recreation vehicles where products such as Exro’s could play a pivotal role.

Ari Berger, Exro’s chief technology officer, called the Aurora partnership a significant milestone in commercialization. “Our partnership with Aurora further proves Exro can be applied and scaled to a wide variety of sectors,” said Berger, who is leading the company’s expansion into sectors such as e-bikes, automotive fleets and the marine industry.

With consumers and companies becoming increasingly aware of their environmental impact, Exro’s portfolio of innovative products and technologies is gaining relevance as the company adds both economic and environmental value. As Exro’s products accelerate the adoption of electric and renewable power systems, the addressable market is virtually inexhaustible. XRO products are applicable not only in electric motors as the single-largest consumer of electricity but also generators and lithium-ion batteries–allowing the company to enter partnerships across a wide variety of sectors.

With its successful track record of financing rounds and valuable intellectual property portfolio consisting of more than 20 existing and pending patents, Exro poses an attractive opportunity for investors seeking to enter high-potential growth markets at an early stage.

For more information, visit the company’s website at www.Exro.com

NOTE TO INVESTORS: The latest news and updates relating to EXROF are available in the company’s newsroom at http://ibn.fm/EXROF

• Nightfood Inc. inundated with orders, supermarket product requests after being featured on Rachael Ray show
• Over 80% of Americans snack regularly at night; most report feeling guilty and out of control
• Nightfood distribution recently expanded to Albertsons’ 188-store Jewel-Osco supermarket chain

Nightfood Holdings Inc. (OTCQB: NGTF), maker of the award-winning, better-for-you ice cream recently endorsed by the American Pregnancy Association as the recommended ice cream for expectant mothers reported a surge in online orders and consumer supermarket requests following a national feature on the Rachael Ray show, along with additional increased demand after adding the Jewel-Osco supermarket chain with 188 locations to its distribution network (http://ibn.fm/MVBwp).

Nightfood ice cream contains more calcium, magnesium, zinc, fiber and protein, all while having less sugar, fewer calories, and a lower glycemic profile. In the segment on the Rachel Ray show, aired the last week in February, world-renowned sleep expert and Nightfood scientific advisor, Dr. Michael Breus introduced Nightfood as a product that can help consumers enjoy a better night’s sleep. Known as the Sleep Doctor(TM) to millions worldwide, Breus is a best-selling author and repeat guest on the show. He has been educating the public about the relationship between our nighttime snack choices and sleep quality for over a decade.

As Nightfood’s scientific advisor, Breus had a profound impact on the birth of Nightfood as a company, and on the formulation of Nightfood products. “Before making the decision to start Nightfood, the writings of Dr. Breus and other experts in the sleep field confirmed for me that our nighttime food choices can directly impact sleep quality,” CEO Sean Folkson commented in a news release (http://ibn.fm/AbGbL).

“Better snacks can lead to better sleep,” he continued. “While our nighttime cravings are biologically hardwired, each of us has a choice in what foods we eat to satisfy those cravings. You can choose a full-fat, full-sugar, sleep-disruptive ice cream and feel guilty and tired… or you can choose Nightfood and feel better physically and emotionally.

“Our website got overwhelmed with traffic a couple of times during the day, and we were inundated with orders and local supermarket product requests,” added Folkson. “With the surge in orders this week, we’ve already surpassed revenues from last quarter, with all of March yet to go.”

In addition to its increase in online orders, Nightfood is also expanding its supermarket reach and will soon be available in all 188 Jewel-Osco supermarket locations starting in late March, company officials announced. The iconic supermarket chain, owned by Albertsons Companies, spans Illinois, Northwest Indiana and Iowa, adding to Nightfood’s fast-growing distribution network which now includes prominent supermarket chains in the Carolinas, Mid-Atlantic, upper Midwest and New England.

With this new distribution, Nightfood ice cream is now available in major divisions of the two largest supermarket chains in the United States (Albertsons and Kroger).

“We’re absolutely thrilled to be bringing Nightfood to Jewel-Osco,” Folkson said. “We’ve got major initiatives planned that will help to quickly introduce thousands of Jewel shoppers to Nightfood and better night snacking.”

Nightfood’s outreach includes social media initiatives through its Nightfood Nation team of sleep experts, world-class athletes, and celebrities who participate in product promotion across their personal channels. In addition to social media, the company has also landed coverage on many major media outlets including the Wall Street Journal, Parents magazine, O, the Oprah Magazine, the Washington Post, the TODAY Show, and USA Today. On the heels of its official recommendation as the Official Ice Cream of the American Pregnancy Association, Nightfood has also been featured in a variety of pregnancy forums like The Bump (http://ibn.fm/aOVWX) and Baby Gaga (http://ibn.fm/7SkO4). As word of Nightfood’s nutritional benefits spreads, supermarket demand to stock the award-winning product is expected to escalate.

Over 250 million American consumers combine to spend over $50 billion annually on snacks consumed between dinner and bed. The most popular choices are understood to be both unhealthy and disruptive to sleep quality. Nightfood solves this problem by helping consumers navigate the unhealthy cravings which are part of our biological human hardwiring. Management believes the nighttime specific snacking category has billion-dollar potential.

For more information, visit the company’s website at www.Nightfood.com

NOTE TO INVESTORS: The latest news and updates relating to NGTF are available in the company’s newsroom at http://ibn.fm/NGTF

• Trading volume increased rapidly during the first four days of trading
• Company has excellent prospects on vacation rental market, which totaled nearly $68 billion in revenue in 2019
• InsuraGuest’s Hospitality Liability Policy covers a wide range of issues, being designed to serve as the first line of defense for guests and properties alike

InsuraGuest Technologies Inc. (TSX.V: ISGI) commenced trading common shares on the TSX Venture Exchange at the opening bell on Friday, February 28, 2020. The company opened with a trading volume of 2,000 shares at $0.4 per share. The price dipped slightly but began rising again as the trading volume increased significantly to more than 200,000 shares over the following days.

Trading volume and share price evolution during the first four days of trading are detailed below:

InsuraGuest Technologies has developed a proprietary insurtech platform, called InsuraGuest, it is designed to deliver specialized insurance products to the hotel and vacation rental market. The specialized guest protection policy, called the Hospitality Liability Policy, serves as the first line of defense for both the property and the guest.

Hotels and vacation rental properties purchase an InsuraGuest Hospitality Liability Policy. This policy is then automatically placed on the guest folio as a mandatory charge at the time of check in. The property pays for the policy on a nightly per-guest basis, which they pass along to the guest, and this is where the company generates revenue.

The platform was created to fill the gap that traditional traveler’s insurance misses, as this type of insurance does not cover a number of things that can happen inside hotels or other travel properties, putting at risk both the traveler and the property owner. People often mistakenly assume that accidents happening at such a property are automatically covered by the property owner’s insurance, but that is not always the case.

Because InsuraGuest extends beyond hotels to the vacation rental industry, the growth potential in companies like Airbnb and VRBO is encouraging for InsuraGuest’s investors. With over $57 billion in rental revenue in 2019 and a growth rate of 6.9% (http://ibn.fm/CFVRH), the vacation rental industry continues to expand as more and more people each year take advantage of the variety of benefits vacations rentals offer.

The company’s insurtech platform can integrate with around 71 different property management systems, giving it access to millions of rooms worldwide and to significant growth opportunities in larger markets. Europe’s hospitality stay market is more than double the market size in the United States, indicating room for significant potential in serving hotel and vacation rental guests with InsuraGuest’s insurance platform.

As the company’s Hospitality Liability Policy covers a wide range of issues, including in-room damage and lost and stolen goods, and provides coverage for accidental, medical, death or dismemberment, InsuraGuest can be a valuable partner to hospital and vacation rental entities, helping them minimize damaging publicity about adverse events by offering a comprehensive insurance solution.

For more information, visit the company’s website at www.InsuraGuest.com

NOTE TO INVESTORS: The latest news and updates relating to ISGI are available in the company’s newsroom at http://ibn.fm/ISGI

• Brands that partner with Vocal see unmatched results, impressive metrics compared to branded content industry averages
• Exclusive Vocal communities offer brands access to authentic partners and ability to target their ideal audience
• Jerrick focuses on creating technology platforms for the creative community and is the parent company of Vocal

Building a brand and establishing a presence in today’s digital-first consumer world is next to impossible without help and support from a tech-savvy strategic partner. Luxury skincare brand FOREO recognized this and chose to partner with Jerrick Media Holdings Inc. (OTC: JMDA), the parent company of the Vocal platform and the Vocal for Brands content studio (http://ibn.fm/ZIt9C).

The result? During the campaign period, FOREO’s website received an 8.4% click through from Vocal’s branded stories – nearly 33 times the industry standard CTR for branded content (http://ibn.fm/XlBmf). The branded content campaign’s initial goal included a Vocal read reach of 25k reads. The campaign exceeded this benchmark by over 10k, resulting in 36,500 engaged readers in the short promotional period (http://ibn.fm/bMYp9).

FOREO, which has been described as “the Apple of the skincare industry,” has 20 million customers worldwide and has grown from two employees to more than 3,000 in the past five years. Yet FOREO officials still recognized the need for a tech partner. Together, Vocal and FOREO created an authentic campaign designed to connect beauty-focused readers on Vocal’s network with FOREO’s brand.

As part of the campaign, Vocal paired FOREO with an existing creator on its beauty community, Blush (http://ibn.fm/AGkeu), to create a series of stories focused on FOREO’s products. The stories included detailed reviews of products and were designed to be informative for FOREO’s current audience while inspiring interest and awareness for readers from the Blush audience.

“By partnering with Vocal for its Winter 2018 campaign, FOREO drove awareness and conversions for its product line to new and existing audiences,” the case study for the campaign reports. “With 36,500 reads, an average CTR of 8.4%, and an interactive female audience representing 97% of total engagement, the branded content campaign successfully resonated with Blush creators and readers.”

FOREO’s experience is not unique. Over and over again, companies report similar results when they partner with Jerrick. The company’s expertise in the development of digital communities and the targeted marketing of branded digital content is unmatched.

Another example is INTIMINA (http://ibn.fm/vKp2j), which offers a range of products dedicated to all aspects of women’s intimate health. The company found ad restrictions around their products’ intimate nature which made traditional marketing and advertising difficult – so they turned to Vocal. Over the period of a year, Vocal and INTIMINA created a series of unique branded stories designed to promote specific products within Vocal’s Viva community (http://ibn.fm/MEJzJ); Viva explores the lives of women from the workplace to home, family, adventure, ambition and beyond (http://ibn.fm/UtTk2).

As detailed in one of the Vocal platform’s case studies (http://ibn.fm/9Cnuo), “Vocal for Brands helped INTIMINA drive awareness and reach new audiences, effectively overcoming the obstacle of restrictions on Facebook and other platforms surrounding themes of women’s health,” the campaign case study reports. “The ongoing campaign has generated over 125,000 reads in total so far and has seen an average CTR of 3% on product-focused campaign stories – a rate that’s 12x the industry standard for branded content. With an average time on page of two and a half minutes, the story series has resulted in over 5,300 hours of engaged readership.”

Jerrick Media Holdings is focused on the development of digital communities, targeted marketing of branded digital content and e-commerce opportunities. To accomplish these objectives, Jerrick envisions, designs and builds modern technology companies that redefine how people interact with technology. As the parent company of Vocal, Jerrick has built and shipped products that have influenced millions of people worldwide.

Those interested in weekly news from Jerrick can sign up at http://ibn.fm/CYErP

For more information, visit the company’s website at https://Jerrick.media

NOTE TO INVESTORS: The latest news and updates relating to JMDA are available in the company’s newsroom at http://ibn.fm/JMDA

• Trxade Group has captured nearly half of the independent pharmacy market with its web-based purchasing platform
• “E-Bay/Kayak-like” Supplier-to-Pharmacy trading platform improves transaction processing between independent pharmacists and drug distributors
• Predictive data analytics features, price visibility and profit optimization within the platform are critical as the general population ages

Trxade Group Inc. (NASDAQ: MEDS) is an integrated pharmaceutical services company that offers a unique combination of a web-based purchasing platform for transactions between independent pharmacists and drug distributors; a network of pharmacies with E-Hub software; a mail order pharmacy; and warehouse and drug delivery services. This synergistic combination of product offerings and superior data analytics is poised to benefit all stakeholders and consumers within the pharmaceutical industry.

The Florida-based Company’s Supplier-to-Pharmacy (“S2P”) trading platform helps independent pharmacies nationwide to identify the best available supplier prices for prescription drugs. With over 11,900 registered pharmacies already on the company’s network, and adding approximately 100 new pharmacies per month, Trxade’s aim is to ultimately reach most of the 24,000 independent pharmacies, with a combined annual purchasing power of over $92 billion.

Trxade targets these independent pharmacies and has demonstrated a significant first-mover advantage over competitors operating similar e-commerce platforms. The company credits effective analytics deployment for the results attained. Trxade leverages a robust, “E-Bay/Kayak-like” technology platform with optimum buyer/seller pricing algorithms, product availability, and predictive data analytics features.

The platform has experienced unparalleled success due to the fact that the company’s business model is designed to overcome general obstacles faced by the typical independent pharmacy. Trxade has found that these pharmacies average annual sales of approximately $3.5 million and the average age of an independent pharmacy owner is greater than 60. Further, independent pharmacies, in order to be cost-effective, often operate with minimal staff and conduct up-to-the minute price checks. The Trxade S2P platform gives these pharmacists the ability to easily compare the price of drugs offered by various suppliers and select the most favorable deals, saving them money by taking advantage of best purchase pricing.

As the general population ages, drug costs are paced to increase faster than overall health care costs and well above inflation. Drug pricing is variable, and reimbursement is squeezing profits. This provides significant opportunity for the Trxade model of price visibility and profit optimization.

The company’s operating strategy is also contributing to its bright outlook for 2020. Trxade’s web-based platform makes it safe, secure and easy to review drugs offered by various suppliers and select the most favorable deals. This increases supplier competition and effectively lowers prices for the pharmacies, enabling them to enjoy larger profit margins.

Information sharing through direct marketing, email marketing, and trade conference attendance, has resulted in the company’s current trend of adding more than 100 pharmacies per month to its user base.

User satisfaction is yet another factor driving success. Pharmacies now have access to quality pharmaceuticals at significant discounts and a large network of suppliers for sales and purchasing opportunities. The analytical and price comparison tools allow for educated buying and selling decisions, easier price comparisons of multiple suppliers with only one search and simplified ordering to suppliers of choice. Customer service is first-class, as Trxade offers close guidance and support to pharmacies for their five initial purchases.

The company believes investors, consumers and industry stakeholders are poised to benefit in the near term from its recent deployment of superior data analytics as well as a platform specifically tailored to current industry needs.

For more information, visit the company’s website at www.TrxadeGroup.com

NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at http://ibn.fm/MEDS

• CEO announces that company will sponsor infomercials touting benefits of CBD oil sold through CBD Biotech Co. subsidiary
• CBD-oil awareness campaign consists of China AM radio infomercial, WeChat group infomercial and New York radio infomercial
• CIIX planning to expand CBD product offerings in China

ChineseInvestors.com Inc. (OTCQB: CIIX) CEO Warren Wang announced during a MoneyTV interview that CIIX is launching a media campaign to raise awareness of the benefits of CBD oil (http://ibn.fm/PqQCy). The multimedia campaign consists of three infomercials: one aired on AM radio in China, one posted on WeChat and one aired on New York radio.

“A lot of people do not understand the benefits of CBD oil,” Wang noted during the broadcast interview. Sharing the benefits of CBD oil is a priority for the company because its China subsidiary, CBD Biotech Co., is expanding its CBD product offerings.

During his interview with MoneyTV host Donald Baillargeon, Wang said the purpose of the media campaign is to raise awareness – and ultimately sales – of CBD oil products offered by CBD Biotech.

“We will have an infomercial in an AM radio show in China for one month to start to create an awareness campaign to explain the benefits of CBD oil and the differences between full-spectrum CBD and CBD isolate,” Wang said. “We believe that CBD oil is very helpful to your health. We see CBD oil as a huge, huge market over the next three-six months.”

The educational infomercial by CIIX shared on a WeChat group site puts the company’s CBD-oil media-awareness campaign at the heart of Chinese social media. WeChat is a multipurpose messaging, social-media and payment app popular with consumers and used for everything from games, video calls, food ordering and news content. WeChat is China’s largest messaging app with a base of more than one billion people. The New York radio infomercial also raises the company’s profile in the United States and with its American audience of Chinese-speaking investors.

In addition to the campaign, CIIX’s website — ChineseInvestors.com — explains the health benefits of CBD oil and details where consumers can buy CBD oil through the company’s online store. Online consumers can also purchase hemp-derived CBD products such as soft gels, capsules and concentrates on the site. The site also educates consumers about CBD, the CBD market and the differences between full-spectrum CBD and CBD isolate.

During the interview, Wang also noted that the company plans on using social-media multiplatform techniques to market CBD products as it moves to boost online sales in China through CBD Biotech Co.

In earlier interviews, Wang noted that, through e-commerce and social-media platform promotion, he sees CBD Biotech reaching profit starting in the fourth quarter of 2020 fiscal year and throughout 2021 fiscal year.

Besides offering its audience of investors real-time market commentary, analysis and educational-related services, CIIX also provides consulting services to smaller private companies looking to go public, in addition to advertising, social media, and public relations consulting services. Based in San Gabriel, California, the company was created in 1999 and went public in 2011.

For more information, visit the company’s website at www.ChineseInvestors.com

NOTE TO INVESTORS: The latest news and updates relating to CIIX are available in the company’s newsroom at http://ibn.fm/CIIX